Try our Advanced Search for more refined results
September 30, 2010
Hospira, Inc. v. Eli Lilly and Company
Case Number:
1:10-cv-06275
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 10, 2011
Lilly, Hospira Settle Gemzar Patent Fight
Eli Lilly & Co. and Hospira Inc. said Tuesday they had reached a settlement in Hospira's Illinois suit seeking a declaration that its planned generic version of cancer drug Gemzar did not infringe a Lilly patent.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login